Ibandronic and chronic obstructive pulmonary disease Patient Reports February 11, 2012
Ibandronic Side Effects Report #4764964-9
Ibandronic side effect was reported by a Physician from UNITED KINGDOM on Aug 24, 2005. Female patient, 66 years of age, weighting 123.5 lb, was diagnosed with osteoporosis postmenopausal and was treated with Ibandronic. After drug was administered, patient experienced the following side effects: back injury, cellulitis
, chronic obstructive pulmonary disease, embolism, gastrointestinal haemorrhage, pulmonary embolism
, sepsis
. Ibandronic dosage: unknown. During the same period patient was treated with ASPIRIN, BECLOMETHASONE DIPROPIONATE, FUROSEMIDE, IPRATROPIUM BROMIDE, ALBUTEROL SULPHATE HFA, SALMETEROL, PREDNISOLONE E. Patient was hospitalized. Patient died on 08/25/2005.Ibandronic Side Effects Report #4892612-6
Ibandronic side effect was reported by a Physician from UNITED KINGDOM on Aug 24, 2005. Female patient, 66 years of age, weighting 123.5 lb, was diagnosed with osteoporosis postmenopausal and was treated with Ibandronic. After drug was administered, patient experienced the following side effects: cellulitis
, chronic obstructive pulmonary disease, duodenal ulcer haemorrhage, embolism, gastrointestinal haemorrhage, pulmonary embolism
, sepsis
. Ibandronic dosage: unknown. During the same period patient was treated with ACETYLSALICYLIC ACID, BECLOMETHASONE DIPROPIONATE, FUROSEMIDE, IPRATROPIUM BROMIDE, SALBUTAMOL, SALMETEROL, PREDNISOLONE E. Patient was hospitalized. Patient died on 08/25/2005.Ibandronic Side Effects Report #5079403-0
Ibandronic side effect was reported by a Physician from UNITED STATES on Dec 22, 2005. Female patient, 75 years of age, weighting 200.6 lb, was diagnosed with osteoporosis
and was treated with Ibandronic. After drug was administered, patient experienced the following side effects: abdominal distension, atrioventricular block second degree, atrioventricular block third degree, bundle branch block right, cardiac failure congestive, cardiomegaly, chest pain
, chronic obstructive pulmonary disease, constipation
. Ibandronic dosage: unknown. During the same period patient was treated with OXYCODONE, GABAPENTIN, COUMADIN, DILTIAZEM, FOSINOPRIL, FUROSEMIDE, ALBUTEROL, POTASSIUM. Patient was hospitalized. Patient recovered.Ibandronic Side Effects Report #5086720-7
Ibandronic side effect was reported by a Physician from UNITED STATES on Dec 22, 2005. Female patient, 75 years of age, weighting 200.6 lb, was diagnosed with osteoporosis
and was treated with Ibandronic. After drug was administered, patient experienced the following side effects: cardiac failure congestive, chest pain
, chronic obstructive pulmonary disease, constipation
, dyspnoea, hypertension, intestinal prolapse. Ibandronic dosage: unknown. During the same period patient was treated with OXYCODONE, GABAPENTIN, COUMADIN, DILTIAZEM, FOSINOPRIL, FUROSEMIDE, ALBUTEROL, POTASSIUM. Patient was hospitalized. Patient recovered.Ibandronic Side Effects Report #5122921-7
Ibandronic side effect was reported by a Physician from UNITED STATES on Dec 22, 2005. Female patient, 75 years of age, weighting 200.6 lb, was diagnosed with osteoporosis
and was treated with Ibandronic. After drug was administered, patient experienced the following side effects: abdominal distension, atrioventricular block second degree, atrioventricular block third degree, bundle branch block right, cardiac failure congestive, cardiac murmur, chest pain
, chronic obstructive pulmonary disease, condition aggravated. Ibandronic dosage: unknown. During the same period patient was treated with OXYCODONE, GABAPENTIN, COUMADIN, DILTIAZEM, FOSINOPRIL, FUROSEMIDE, ALBUTEROL, POTASSIUM. Patient was hospitalized. Patient recovered.Ibandronic Side Effects Report #5693287-9
Ibandronic side effect was reported by a Consumer or non-health professional from UNITED STATES on Mar 24, 2008. Female patient, 67 years of age, was diagnosed with osteoporosis
and was treated with Ibandronic. After drug was administered, patient experienced the following side effects: chronic obstructive pulmonary disease. Ibandronic dosage: unknown. Patient died on 08/26/2007.Ibandronic Side Effects Report #6034261-2
Ibandronic side effect was reported by a Consumer or non-health professional from UNITED STATES on Jan 06, 2009. Female patient, 87 years of age, was treated with Ibandronic. After drug was administered, patient experienced the following side effects: chronic obstructive pulmonary disease, pneumonia
. Ibandronic dosage: unknown. Patient was hospitalized. Patient died.Ibandronic Side Effects Report #5682391-7
Ibandronic side effect was reported by a Consumer or non-health professional from UNITED STATES on Mar 19, 2008. Female patient, 84 years of age, was treated with Ibandronic. After drug was administered, patient experienced the following side effects: chronic obstructive pulmonary disease, pneumonia
. Ibandronic dosage: unknown. Patient died on 03/15/2008.Ibandronic Side Effects Report #6109037-8
Ibandronic side effect was reported by a Consumer or non-health professional from UNITED STATES on Mar 05, 2009. Female patient, 79 years of age, was treated with Ibandronic. After drug was administered, patient experienced the following side effects: chronic obstructive pulmonary disease. Ibandronic dosage: unknown. Patient died on 03/17/2008.
Ibandronic Side Effects Report #5833575-6
Ibandronic side effect was reported by a Consumer or non-health professional from UNITED STATES on July 28, 2008. Female patient, 71 years of age, was treated with Ibandronic. After drug was administered, patient experienced the following side effects: chronic obstructive pulmonary disease. Ibandronic dosage: unknown. During the same period patient was treated with SPIRIVA, FORADIL, CALCIUM. Patient was hospitalized. Patient recovered.
Ibandronic and chronic obstructive pulmonary disease 